Scottsdale Research Institute

The following diseases or conditions are additional areas of interest for future funding and research:

• Substitution therapy for opioid dependence, benzodiazepine withdrawal etc.
• Agitation in Alzheimer's disease
• Severe appetite suppression, weight loss, and cachexia due to HIV infection and other medical conditions
• Chronic pain, particularly neuropathic pain
• Severe nausea and vomiting associated with cancer and its treatment
• Severe muscle spasticity caused by diseases such as multiple sclerosis
• Autism, Autism Spectrum Disorders and other pervasive developmental disorders.

SRI also seeks to highlight and raise awareness of current barriers to cannabis research caused by Drug War-era policies and legislation.

SRI does not encourage or sanction the social or recreational use of cannabis, but supports the expansion of research efforts to determine the applicability of cannabis as medicine for any conditions for which it might prove safe and effective.

The SRI Institute will coordinate and support cannabis research throughout the State of Arizona and beyond. Research will focus on the potential medicinal benefits of cannabis for diseases and conditions as specified by the National Academy of Sciences, Institute of Medicine Report (1999) and by the Workshop on the Medical Utility of Marijuana, National Institutes of Health (1997).